Nxera Pharma (4565.T)

P/S ratio at the end of 2024: 3.27

According to Nxera Pharma's latest financial reports and stock price the company's current price-to-sales ratio (TTM) is 1.09. At the end of 2024 the company had a P/S ratio of 3.27.

P/S ratio history for Nxera Pharma from 2005 to 2024

PS ratio at the end of each year

Year	P/S ratio	Change
2024	3.27	-64.37%
2023	9.16	-18.53%
2022	11.3	28.38%
2021	8.76	-46.59%
2020	16.4	-4.63%
2019	17.2	-28.81%
2018	24.2	148.16%
2017	9.74	-70.99%
2016	33.6	195.69%
2015	11.4	-35.35%
2014	17.6	-11.82%
2013	19.9	23.17%
2012	16.2	-1.75%
2011	16.5	22.35%
2010	13.4	-39.23%
2009	22.1	83.73%
2008	12.0	-54.78%
2007	26.6	-68.73%
2006	85.2	-38.74%
2005	139

What is the market capitalization of a company?

The market capitalization sometimes referred as Marketcap, is the value of a publicly listed company.
In most cases it can be easily calculated by multiplying the share price with the amount of outstanding shares.

DISCLAIMER

CompaniesMarketCap is not associated in any way with CoinMarketCap.com
Stock prices are delayed, the delay can range from a few minutes to several hours.
Company logos are from the CompaniesLogo.com logo database and belong to their respective copyright holders. Companies Marketcap displays them for editorial purposes only.

Contact

For inquiries or if you want to report a problem write to hello@8marketcap.com

Links

- Privacy policy

- Terms and conditions

P/S ratio for Nxera Pharma (4565.T)